Experimentally, navitoclax kills cells in the BAX/BAK-dependent way and leads to regression of lymphoid tumors in xenograft models. In animal experiments, navitoclax was found to get a senolytic agent, inducing apoptosis in senescent, although not non-senescent cells.[four] Oral administration of ABT263 to both sublethally irradiated or Ordinarily aged mice diminished https://tak-24365431.activablog.com/25894493/the-smart-trick-of-lp-935509-that-no-one-is-discussing